PLSE NASDAQ
Miami, FL 33131
US
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Teplitsky Liane Rae | P-Purchase | 1,001 | $49.95 | 2026-09-01 |
| Teplitsky Liane Rae | P-Purchase | 1,024 | $48.80 | 2026-08-31 |
| Teplitsky Liane Rae | P-Purchase | 1,034 | $48.35 | 2026-08-28 |
| Teplitsky Liane Rae | P-Purchase | 1,036 | $48.23 | 2026-08-26 |
| Teplitsky Liane Rae | A-Award | 200,000 | — | 2026-08-08 |